Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl-

Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl- Struktur
132813-13-9
CAS-Nr.
132813-13-9
Englisch Name:
Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl-
Synonyma:
BlonserinImpurity29;Blonanserin impurity 08;Blonanserin Impurity 29;Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl-
CBNumber:
CB59748117
Summenformel:
C17H18ClN
Molgewicht:
271.78
MOL-Datei:
132813-13-9.mol

Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl- Eigenschaften

Siedepunkt:
416.5±45.0 °C(Predicted)
Dichte
1.122±0.06 g/cm3(Predicted)
pka
1.71±0.20(Predicted)

Sicherheit

Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl- Chemische Eigenschaften,Einsatz,Produktion Methoden

Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Jinan blalong chemical co. LTD 2710913286@.com
1513643261@qq.com China 14253 58
Jiangsu Wansipu Technology Co., Ltd. 17826022701
1485609990@qq.com China 939 58
Nanjing Shanyao Kangcheng biomedical Co., Ltd. 15722982350
1170703875@qq.com China 523 58
Molcoo Chemicals Inc. 18627923403 18627753421
3001006472@qq.com China 9366 58
Hunan Zengda Biological Technology Co., LTD 18711085600
1652923704@qq.com China 4583 58
Shanghai YuZn Pharm. Technology Co.,Ltd. 15921286451; 15921286451
2010681527@qq.com China 5073 58
Nanjing Huanuo Biomedical Technology Co., Ltd 18913906212
2885426135@qq.com China 6789 58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd 18102736234 18102736234
2208093734@qq.com China 7664 58

  • Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl-
  • BlonserinImpurity29
  • Blonanserin Impurity 29
  • Blonanserin impurity 08
  • 132813-13-9
Copyright 2019 © ChemicalBook. All rights reserved